Orgaran Interactions
There are 172 drugs known to interact with Orgaran (danaparoid), along with 7 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 95 are major, 71 are moderate, and 6 are minor.
- View all 172 medications that may interact with Orgaran
- View Orgaran alcohol/food interactions (1)
- View Orgaran disease interactions (7)
Most frequently checked interactions
View interaction reports for Orgaran (danaparoid) and the medicines listed below.
- acetazolamide
- Acidophilus Probiotic Blend (lactobacillus acidophilus)
- Acova (argatroban)
- Advair Diskus (fluticasone / salmeterol)
- albuterol
- Allegra (fexofenadine)
- alprazolam
- Angiomax (bivalirudin)
- apixaban
- argatroban
- Arixtra (fondaparinux)
- Arnuity Ellipta (fluticasone)
- Atrovent (ipratropium)
- Azithromycin Dose Pack (azithromycin)
- baclofen
- benzocaine topical
- benzonatate
- betrixaban
- Bevyxxa (betrixaban)
- bisacodyl
- bivalirudin
- Breo Ellipta (fluticasone / vilanterol)
- brimonidine ophthalmic
- Bumex (bumetanide)
- Catapres (clonidine)
- cetirizine
- chlorhexidine topical
- chlorpheniramine
- ciprofloxacin
- Lovenox (enoxaparin)
Orgaran alcohol/food interactions
There is 1 alcohol/food interaction with Orgaran (danaparoid).
Orgaran disease interactions
There are 7 disease interactions with Orgaran (danaparoid) which include:
- hemophilia
- liver disease
- peptic ulcer disease
- retinopathy
- subacute bacterial endocarditis
- hypertension
- kidney disease
More about Orgaran (danaparoid)
- Orgaran consumer information
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: heparins
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.